Chapter 59

Reference

  1. Armengou A, Porcar C, Mascaro J, et al. 1996. Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis 23:1337-1338.
  2. 1a. Baddley JW, Schain DC, Gupte AA, et al. 2011. Transmission of Cryptococcus neoformans by organ transplantation. Clin Infect Dis 52:e94-e98.
  3. Bailly MP, Boibieux A, Biron F, et al. 1991. Persistence of Cryptococcus neoformans in the prostate: failure of fluconazole despite high doses. J Infect Dis 164:435-436.
  4. Barrs VR, Martin P, Nicoll RG, et al. 2000. Pulmonary cryptococcosis and Capillaria aerophila infection in an FIV-positive cat. Aust Vet J 78:154-158.
  5. Bartlett KH, Fyfe MW, MacDougall LA. 2003. Environmental Cryptococcus neoformans var gattii in British Columbia, Canada. Am J Respir Crit Care Med 167:A499.
  6. Bartlett KH, Kidd SE, Kronstad JW. 2008. The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Curr Infect Dis Rep 10:58-65.
  7. Beatty JA, Barrs VB, Swinney GR, et al. 2000. Peripheral vestibular disease associated with cryptococcosis in three cats. J Feline Med Surg 2:29-34.
  8. Belluco S, Thibaud JL, Guillot J, et al. 2008. Spinal cord cryptococcoma in an immunocompetent cat. J Comp Pathol 139:246-251.
  9. Bemis DA, Krahwinkel DJ, Bowman LA, et al. 2000. Temperature-sensitive strain of Cryptococcus neoformans producing hyphal elements in a feline nasal granuloma. J Clin Microbiol 38:926-928.
  10. Bernardo FM, Martins HM, Martins ML. 1998. A survey of mycotic otitis externa of dogs in Lisbon. Rev Iberoam Micol 15:163-165.
  11. Berthelin CF, Bailey CS, Kass PH, et al. 1994. Cryptococcosis of the nervous system in dogs: part 1. Epidemiologic, clinical, and neuropathologic features. Prog Vet Neurol 5:88-97.
  12. Berthelin CF, Legendre AM, Bailey CS, et al. 1994. Cryptococcosis of the nervous system in dogs: part 2. Diagnosis, treatment, monitoring, and prognosis. Prog Vet Neurol 5:136-146.
  13. Bicanic T, Harrison TS. 2005. Cryptococcal meningitis. Br Med Bull 72:99-118.
  14. Blevins LB, Fenn J, Segal H, et al. 1995. False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps. J Clin Microbiol 33:1674-1675.
  15. Blouin P, Cello RM. 1980. Experimental ocular cryptococcosis. Preliminary studies in cats and mice. Invest Ophthalmol Vis Sci 19:21-30.
  16. Bowles B, Fry DR. 2009. Nasal cryptococcosis in two dogs in New Zealand. N Z Vet J 57:53-57.
  17. Bozzette SA, Larsen RA, Chiu J, et al. 1991. Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS. Ann Intern Med 115:285-286.
  18. Brandt ME, Pfaller MA, Hajjeh RA, et al. 1996. The Cryptococcal Disease Active Surveillance Group. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis. J Infect Dis 174:812-820.
  19. Brocklebank J. 1997. British Columbia: canine Cryptococcus neoformans. Can Vet J 38:724.
  20. Buchanan KL, Murphy JW. 1998. What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 4:71-83.
  21. Buergelt DD. 2001. Cryptococcosis in cats. Vet Med Mar:187-194.
  22. 20a. Burns RE, Mohr FC. 2010. Pathology in Practice. Severe chronic multifocal to coalescing granulomatous meningoencephalitis, rhinitis, sinusitis, with intralesional yeasts consistent with Cryptococcus spp. J Am Vet Med Assoc 236:1069-1070.
  23. Byrnes EJ, Bildfell RJ, Dearing PL, et al. 2009. Cryptococcosis gattii with bimorphic colony types in a dog in western Oregon: additional evidence of expansion of the Vancouver Island outbreak. J Vet Diagn Invest 21:133-136.
  24. Campbell LT, Fraser JA, Nichols CB, et al. 2005. Clinical and environmental isolates of Cryptococcus gattii from Australia that retain sexual fecundity. Eukaryot Cell 4:1410-1419.
  25. 22a. Carriconde F, Gilgado F, Arthur I, et al. 2011. Clonality and α-a recombination in the Australian Cryptococcus gattii VGII population-An emerging outbreak in Australia. PLoS One 6: e16936.
  26. Casadevall A. 2010. Cryptococci at the brain gate: break and enter or use a Trojan horse? J Clin Invest 120:1389-1391.
  27. Castella G, Abarca ML, Cabanes FJ. 2008. Cryptococcosis in companion animals. Rev Iberoam 25:S19-S24.
  28. Chapman TL, Kirk SE. 2008. An isolated cryptococcal urinary tract infection in a cat. J Am Vet Med Assoc 44:262-2265.
  29. Chaturvedi S, Dyavaiah M, Larsen RA, et al. 2005. Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis 11:1686-1692.
  30. Chen SCA, Muller M, Zhou JZ, et al. 1997. Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis 175:414-420.
  31. Chrétien F, Lortholary O, Kansau I, et al. 2002. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 186:522-530.
  32. Chuck SL, Sande MA. 1989. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 321:794-799.
  33. Datta K, Bartlett KH, Baer R, et al. 2009. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis 15: [serial on the Internet] Available from http://www.cdc.gov/EID/content/15/8/1185.htm.
  34. Datta K, Bartlett KH, Marr KA. 2009. Cryptococcus gattii: Emergence in Western North America: exploitation of a novel ecologic niche. Perspect Inf Dis 10: 2009.
  35. Demko JL, Cohn LA. 2007. Chronic nasal discharge in cats: 75 cases (1993-2004). J Am Vet Med Assoc 230:1032-1037.
  36. Denning DW, Tucker RM, Hanson LH, et al. 1989. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 149:2301-2308.
  37. Dimech WJ. 1990. Diagnosis, identification and epidemiology of Cryptococcus neoformans infection. Aust J Med Lab Sci 12:13-21.
  38. Dong ZM, Murphy JW. 1995. Intravascular cryptococcal culture filtrate (cneF) and its major component glucuronoxylomannan (Gxm) are potent inhibitors of leukocyte accumulation. Infect Immun 63:770-778.
  39. Duncan C, Schweantje H, Stephen C, et al. 2006. Cryptococcus gattii in wildlife of Vancouver island, British Columbia, Canada. J Wildl Dis 42:175-178.
  40. Duncan C, Stephen C, Lester S, et al. 2005. Follow-up study of dogs and cats with asymptomatic Cryptococcus gattii infection or nasal colonization. Med Mycol 43:663-6636.
  41. Duncan C, Stephen C, Lester S, et al. 2005. Sub-clinical infection and asymptomatic carriage of Cryptococcus gattii in dogs and cats during an outbreak of cryptococcosis. Med Mycol 43:511-5116.
  42. Duncan C, Stephen C, Campbell J. 2006. Clinical characteristics and predictors of mortality for Cryptococcus gattii infection in dogs and cats of southwestern British Columbia. Can Vet J 47:993-998.
  43. Duncan CG, Stephen C, Campbell J. 2006. Evaluation of risk factors for Cryptococcus gattii infections in dogs and cats. J Am Vet Med Assoc 228:377-382.
  44. Ellis DH, Pfeiffer TJ. 1990. Ecology, life cycle and infectious propagule of Cryptococcus neoformans. Lancet 336:923-925.
  45. Ellis DH, Pfeiffer TJ. 1990. Natural habitat of Cryptococcus neoformans var gattii. J Clin Microbiol 28:1642-1644.
  46. Flatland B, Greene RT, Lappin MR. 1996. Clinical and serologic evaluation of cats with cryptococcosis. J Am Vet Med Assoc 209:1110-1113.
  47. Foster SF, Charles JA, Parker G, et al. 2000. Cerebral cryptococcal granuloma in a cat. J Feline Med Surg 2:201-206.
  48. Foster SF, Parker G, Churcher RM, et al. 2001. Intracranial cryptococcal granuloma in a cat. J Feline Med Surg 3:39-44.
  49. Franzot SP, Hamdan JS, Currie BP, et al. 1997. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J Clin Microbiol 35:2243-2251.
  50. Fyfe M, MacDougall L, Romney M, et al. 2008. Cryptococcus gattii infections on Vancouver Island, British Columbia, Canada: emergence of a tropical fungus in a temperate environment. Can Commun Dis Rep 34:1-12.
  51. Garcia-Hermoso D, Janbon G, Dromer F. 1999. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 37:3204-3209.
  52. Georgi A, Schneemann M, Tintelnot K, et al. 2009. Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure. Infection 37:370-373.
  53. Gerds-Grogan S, Dayrell-Hart B. 1997. Feline cryptococcosis, a retrospective evaluation. J Am Anim Hosp Assoc 33:118-122.
  54. Glass E, De Lahunta A, Kent M. 1996. A cryptococcal granuloma in the brain of a cat causing focal signs. Prog Vet Neurol 7:141-144.
  55. Gordon MA, Casadevall A. 1995. Serum therapy for cryptococcal meningitis. Clin Infect Dis 21:1477-1479.
  56. Graves TK, Barger AM, Adams B, et al. 2006. Diagnosis of systemic cryptococcosis by fecal cytology in a dog. Vet Clin Pathol 34:409-412.
  57. Gray LD, Roberts GD. 1988. Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen. J Clin Microbiol 26:2450-2451.
  58. Halliday CL, Bui T, Krockenberger M, et al. 1999. Presence of α and a mating types in environmental and clinical collections of Cryptococcus neoformans var gattii from Australia. J Clin Microbiol 37:2920-2926.
  59. Hamilton JR, Noble A, Denning DW, et al. 1991. Performance of Cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment. J Clin Microbiol 29:333-339.
  60. Hay RJ. 1994. Antifungal drugs on the horizon. J Am Acad Dermatol 31:S82-S85.
  61. Himmelreich U, Dzendrowskyj TE, Allen C, et al. 2001. Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. Radiology 220:122-128.
  62. Hofmann S, Heider HJ, Hinrichs V, et al. 1997. Systemic cryptosporidiosis in a dog. Case report. Tierarztl Umschau 52:100-106.
  63. Hospenthal DR, Bennett JE. 1998. Flucytosine monotherapy for cryptococcosis. Clin Infect Dis 27:260-264.
  64. Hubert B, Magnol JP. 1985. Cutaneous cryptococcosis in a cat infected with the leukaemogenic virus. Pratique Medicale Chirurgicale L’Animal de Compagnie 20:253-256.
  65. Hull CM, Heitman J. 2002. Genetics of Cryptococcus neoformans. Annu Rev Genet 36:557-615.
  66. Hunt GB, Perkins M, Foster SF, et al. 2002. Nasopharyngeal disease: a review of 60 cases. Compend Cont Educ Pract Vet 24:184-200.
  67. Jacobs GJ, Greene CE, Medleau L. 1998. Feline and canine cryptococcosis. Waltham Focus 8:21-27.
  68. Jacobs GJ, Medleau L. 1998. Cryptococcosis, pp 383-390. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  69. Jacobs GJ, Medleau L, Calvert CC, et al. 1997. Cryptococcal infection in cats: factors influencing treatment outcome, and results of sequential serum antigen titers in 35 cats. J Vet Intern Med 11:1-4.
  70. Jain N, Fries BC. 2008. Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii. Mycopathologia 166:181-188.
  71. Kano R, Fujino Y, Takamoto N, et al. 2001. PCR detection of the Cryptococcus neoformans CAP59 gene from a biopsy specimen from a case of feline cryptococcosis. J Vet Diagn Invest 13:439-442.
  72. Kano R, Hosaka S, Hasegawa A. 2004. First isolation of Cryptococcus magnus from a cat. Mycopathologia 157:263-264.
  73. Kano R, Kitagawat M, Oota S, et al. 2008. First case of feline systemic Cryptococcus albidus infection. Med Mycol 46:75-77.
  74. Karnik K, Reichle JK, Fischetti AJ, et al. 2009. Computed tomographic findings of fungal rhinitis and sinusitis in cats. Vet Radiol Ultrasound 50:65-68.
  75. Kerwin SC, McCarthy RJ, VanSteenhouse JL, et al. 1998. Cervical spinal cord compression caused by cryptococcosis in a dog: successful treatment with surgery and fluconazole. J Am Anim Hosp Assoc 34:523-526.
  76. Kitchen LW. 1996. Adjunctive immunologic therapy for Cryptococcus neoformans infections. Clin Infect Dis 23:209.
  77. Kluger EK, Karaoglu HK, Krockenberger MB, et al. 2006. Recrudescent cryptococcosis, caused by Cryptococcus gattii (molecular type VGII), over a 13-year period in a birman cat. Med Mycol 44:561-566.
  78. Krawiec DR, McKiernan BC, Twardock AR, et al. 1996. Use of amphotericin B lipid complex for treatment of blastomycosis in dogs. J Am Vet Med Assoc 209:2073-2075.
  79. Krockenberger MB, Canfield PJ, Barnes J, et al. 2002. Cryptococcus neoformans variety gattii in the koala (Phascolarctos cinereus): serological evidence for subclinical cryptococcosis. Med Mycol 40:273-282.
  80. Krockenberger MB, Canfield PJ, Kozel TR, et al. 2001. An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissues. Med Mycol 39:523-533.
  81. Krockenberger MB, Malik R, Canfield PJ. 2002. Cryptococcus neoformans in the koala (Phascolarctos cinereus): colonisation by variety gattii and investigation of environmental sources. Med Mycol 40:263-272.
  82. 78a. Krockenberger MB, Malik R, Ngamskulrungro P, et al. 2010. Pathogenesis of pulmonary Cryptococcus gatgtii infection: a rat model. Mycopathologica 170:315-330.
  83. 78b. Krockenberger MB, Swinney G, Martin P, et al. 2011. Sequential opportunistic infections in two German shepherd dogs. Aust Vet J 89:9-14.
  84. Kwon-Chung KJ. 1976. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 68:821-833.
  85. Kwon-Chung KJ, Boekhout T, Fell JW, et al. 2002. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 51:804-806.
  86. Kwon-Chung KJ, Polacheck I, Bennett JE. 1982. Improved diagnostic medium for separation of Cryptococcus neoformans var neoformans (serotypes A & D) and Cryptococcus neoformans var gattii (serotypes B & C). J Clin Microbiol 15:535-537.
  87. Kwon-Chung KJ, Sorrell TC, Dromer F, et al. 2000. Cryptococcosis: clinical and biological aspects. Med Mycol 3 8(Suppl 1):205-213.
  88. Kwong EH, Ramaswamy M, Bauer EA, et al. 2001. Heat treatment of amphotericin B modifies its serum pharmacokinetics, tissue distribution, and renal toxicity following administration of a single intravenous dose to rabbits. Antimicrob Agents Chemother 45:2060-2063.
  89. Labrecque O, Sylvestre D, Messier S. 2005. Systemic Cryptococcus albidus infection in a Doberman pinscher. J Vet Diagn Invest 17:598-600.
  90. Lambert RJ, Levin G, Wendelburg K, et al. 2006. What's your diagnosis? Cryptococcosis. J Am Vet Med Assoc 229:931-932.
  91. Lamothe J. 2003. Personal communication. 1 Rond-Point la de Roya, 06510 Carros, France.
  92. Lazera MS, Pires FDA, Camillo-Coura L, et al. 1996. Natural habitat of Cryptococcus neoformans var neoformans in decaying wood forming hollows in living trees. J Med Vet Mycol 34:127-131.
  93. Lester SJ, Kowalewich NJ, Bartlett KH, et al. 2004. Clinicopathologic features of an unusual outbreak of cryptococcosis in dogs, cats, ferrets and a bird: 38 cases (January to July 2003). J Am Vet Med Assoc 225:1716-1722.
  94. Liaw YS, Yang PC, Yu CJ, et al. 1995. Direct determination of cryptococcal antigen in transthoracic needle aspirate for diagnosis of pulmonary cryptococcosis. J Clin Microbiol 33:1588-1591.
  95. Lorente-Mendez C, Martinez CM, Corpa JM. 2009. Pathology in practice. Systemic cryptococcosis caused by C. neoformans and concomitant severe pulmonary aleurostrongylosis. J Am Vet Med Assoc 235: 1407-1409.
  96. MacDougall L, Fyfe M. 2006. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol 44:1851-1852.
  97. MacDougall L, Kidd SE, Galanis E, et al. 2007. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis 13:42-50.
  98. Madewell BR, Holmberg CA, Ackerman N. 1979. Lymphosarcoma and cryptococcosis in a cat. J Am Vet Med Assoc 175:65-68.
  99. Malik R, Alderton B, France MP, et al. 2002. Cryptococcosis in ferrets: a wide spectrum of clinical disease. Aust Vet J 80:749-755.
  100. Malik R, Craig AJ, Wigney D, et al. 1996. Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B. Aust Vet J 73:124-128.
  101. Malik R, Dill-Macky E, Martin P, et al. 1995. Cryptococcosis in dogs: a retrospective study of 20 consecutive cases. J Vet Med Mycol 33:291-297.
  102. Malik R, Hunt GB, Bellenger CR, et al. 1999. Intra-abdominal cryptococcosis in two dogs. J Small Anim Pract 40:387-391.
  103. Malik R, Krockenberger MB, Cross G, et al. 2003. Avian cryptococcosis. Med Mycol 41:115-124.
  104. 98a. Malik R, Krockenberger MB, O’Brien CR, et al. 2011. Veterinary insights into cryptococcosis caused by Cryptococcus neoformans and Cryptococcus gattii. In Heitman J et al (eds) Cryptococcus: from Human Pathogen to Model Yeast. ASM Press, Washington DC.
  105. Malik R, Martin P, Wigney DI, et al. 1997. Nasopharyngeal cryptococcosis. Aust Vet J 75:483-488.
  106. Malik R, McPetrie R, Wigney D, et al. 1996. A latex cryptococcal antigen agglutination test for diagnosis and monitoring of therapy for cryptococcosis. Aust Vet J 74:358-364.
  107. Malik R, Medeiros C, Wigney D, et al. 1996. Suspected drug eruption in dogs during administration of flucytosine. Aust Vet J 74:285-288.
  108. Malik R, Speed B, Kaldor J, et al. 1999. Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection. Med Mycol 37:43-51.
  109. Malik R, Vogelnest L, O’Brien CR, et al. 2004. Infections and some other conditions affecting the skin and subcutis of the naso-ocular region of cats, J Feline Med Surg 6:383-390.
  110. Malik R, Wigney DI, Muir DB, et al. 1992. Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally-administered fluconazole. J Med Vet Mycol 30:133-144.
  111. Malik R, Wigney DI, Muir DB, et al. 1997. Asymptomatic carriage of Cryptococcus neoformans in the nasal cavity of dogs and cats. J Med Vet Mycol 35:27-31.
  112. Martin CL, Stiles J, Willis M. 1996. Ocular adnexal cryptococcosis in a cat. Vet Comp Ophthalmol 6:225-229.
  113. McGill S, Malik R, Saul N, et al. 2009. Cryptococcosis in domestic animals in Western Australia: a retrospective study from 1995-2006. Med Mycol 47:625-639.
  114. McLellan GJ, Aquino SM, Mason DR, et al. 2006. Use of posaconazole in the management of invasive orbital aspergillosis in a cat. J Am Anim Hosp Assoc 42:302-307.
  115. McNamara TS, Cook RA, Behler JL, et al. 1994. Cryptococcosis in a common anaconda (Eunectes murinus). J Zoo Wildl Med 25:128-132.
  116. Meadows RL, MacWilliams PS, Dzata G, et al. 1993. Chylothorax associated with cryptococcal mediastinal granuloma in a cat. Vet Clin Pathol 22:109-116.
  117. Medleau L, Barsanti JB. 1990. Cryptococcosis, pp 687-695. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  118. Medleau L, Greene CE, Rakich PM. 1990. Evaluation of ketoconazole and itraconazole for treatment of disseminated cryptococcosis in cats. Am J Vet Res 51:1454-1458.
  119. Medleau L, Jacobs GJ, Marks MA. 1995. Itraconazole for the treatment of cryptococcosis in cats. J Vet Intern Med 9:39-42.
  120. Medleau L, Marks MA, Brown J, et al. 1990. Clinical evaluation of a cryptococcal antigen latex agglutination test for diagnosis of cryptococcosis in cats. J Am Vet Med Assoc 196:1470-1473.
  121. Megson GM, Stevens DA, Hamilton JR, et al. 1996. D-Mannitol in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. J Clin Microbiol 34:218-221.
  122. Meric Taylor S. 1998. Diagnostic tests for the neuromuscular system, pp 955-969. In Nelson RW, Couto CG (eds): Small animal internal medicine. Mosby, St Louis.
  123. Mikiciuk MG, Fales WH, Schmidt D. 1990. Successful treatment of feline cryptococcosis with ketoconazole and flucytosine. J Am Anim Hosp Assoc 26:199-201.
  124. Millon L, Barale T, Julliot MC, et al. 1995. Interference by hydroxyethyl starch used for vascular filling in latex agglutination test for cryptococcal antigen. J Clin Microbiol 33:1912-1919.
  125. Mitchell DH, Sorrell TC, Allworth AM, et al. 1995. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 20:611-616.
  126. Moncino MD, Gutman LT. 1990. Severe systemic cryptococcal disease in a child: review of prognostic indicators predicting treatment failure and an approach to maintenance therapy with oral fluconazole. Pediatr Infect Dis J 9:363-368.
  127. Neuville S, Dromer F, Morin O, et al. 2003. The French Cryptococcosis Study Group. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis 36:337-347.
  128. Ngamskulrungroj P, Gilgado F, Faganello J et al. 2009. Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One 4(6): e5862.
  129. Nielsen K, De Obaldia AL, Heitman J. 2007. Cryptococcus neoformans mates on pigeon guano: implications for the realized ecological niche and globalization. Eukaryot Cell 6:949-959.
  130. Nosanchuk JD, Shoham S, Fries BC, et al. 2000. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med 132:205-208.
  131. O’Brien CR, Krockenberger MB, Wigney DI, et al. 2004. Retrospective study of feline and canine cryptococcosis in Australia from 1981 to 2001: 195 cases. Med Mycol 42:449-460.
  132. O’Brien CR, Krockenberger MB, Martin P, et al. 2006. Long-term outcome of therapy for 59 cats and 11 dogs with cryptococcosis. Aust Vet J 84:384-392.
  133. Okabayashi K, Kano R, Sirouzu K, et al. 2003. Detection of CAP59 gene in 2 feline cases of systemic cryptococcosis. J Vet Med Sci 65:953-955.
  134. O’Toole TE, Sato AF, Rozanski EA. 2003. Cryptococcosis of the central nervous system in a dog. J Am Vet Med Assoc 222:1722-1725.
  135. Perfect JR. 2005. Cryptococcus neoformans, pp 2997-3012. In Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases, ed 6. Elsevier Churchill Livingstone, Philadelphia.
  136. Perfect JR. 2005b. Cryptococcus neoformans: a sugar-coated killer with designer genes. FEMS Immunol Med Microbiol 45:395-404.
  137. Petit C, Yardley V, Gaborinau, F, et al. 1999. Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovani. Antimicrob Agents Chemother 43:390-392.
  138. Phillips P, Chapman K, Sharp M, et al. 2009. Dexamethasone in Cryptococcus gattii central nervous system infection. Clin Infect Dis 49:591-595.
  139. 132a. Poth T, Seibold M, Werckenthin C, et al. 2010. First report of a Cryptococcus magnus infection in a cat. Med Mycol 48:1000-1004.
  140. Rappelli P, Are R, Casu G, et al. 1998. Development of a nested PCR for detection of Cryptococcus neoformans in cerebrospinal fluid. J Clin Microbiol 36:3438-3440.
  141. Saag MS, Graybill RJ, Larsen RA, et al. 2000. The Mycoses Study Group Cryptococcal Subproject. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 30:710-718.
  142. Sanfelice F. 1894. Contributo alla morfologia e biolgia dei blastomiceti che si sviluppano nei succi di alcuni frutti. Ann Ig 4:463-495.
  143. Shaw SE. 1988. Successful treatment of 11 cases of feline cryptococcosis. Aust Vet Pract 18:135-139.
  144. Suchodolski JS, Morris EK, Allenspach K, et al. 2008. Prevalence and identification of fungal DNA in the small intestine of healthy dogs and dogs with chronic enteropathies. Vet Microbiol 132:379-388.
  145. Sorrell TC. 2001. Cryptococcus neoformans variety gattii. Med Mycol 39:155-168.
  146. Speed B, Dunt D. 1995. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 21:28-34.
  147. Stephen C, Lester S, Black W, et al. 2002. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J 43:792-794.
  148. Sukroongreung S, Kitiniyom K, Nilakul C, et al. 1998. Pathogenicity of basidiospores of Filobasidiella neoformans var neoformans. Med Mycol 36:419-424.
  149. Sykes JE, Sturges BK, Cannon MS, et al. 2010. Clinical signs, imaging features, neuropathology and outcome in cats and dogs with central nervous system cryptococcosis from California. J Vet Intern Med 24:1427-1438.
  150. Tanaka K, Miyazaki T, Maesaki S, et al. 1996. Detection of Cryptococcus neoformans gene in patients with pulmonary Cryptococcus. J Clin Microbiol 34:2826-2828.
  151. Tanner DC, Weinstein MP, Fedorciw B, et al. 1994. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 32:1680-1684.
  152. Thompson GR 3rd, Cadena J, Patterson TF. 2009. Overview of antifungal agents. Clin Chest Med 30:203-215.
  153. Thompson GR 3rd, Wiederhold NP, Fothergill AW, et al. 2009. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrob Agents Chemother 53:309-311.
  154. Tiches D, Vite CH, Dayrell-Hart B, et al. 1998. A case of canine central nervous system cryptococcosis: management with fluconazole. J Am Anim Hosp Assoc 34:145-151.
  155. Tisdall PLC, Martin P, Malik R. 2007. Cryptic disease in a cat with painful and swollen hocks: an exercise in diagnostic reasoning and clinical decision making. J Feline Med Surg 9:418-423.
  156. Tjalsma EJ. 1997. Two cases of cryptococcosis in the cat. Tijdschrift Diergeneesk 122:128-132.
  157. 149a. Trivedi SR, Malik R, Meyer W, et al. 2011. Feline cryptococcosis, how recent is research improving clinical understanding. J Feline Med Surg 13:163-172.
  158. Trivedi SR, Sykes JE, Cannon MS, et al. 2010. Variation in clinical presentation and epidemiology of cryptococcosis in cats and dogs from California. J Am Vet Med Assoc Accepted.
  159. Turner SH, Cherniak R. 1991. Multiplicity in the structure of the glucuronoxylomannan of Cryptococcus neoformans, pp 123-142. In Latge JP, Boucias D (eds): Fungal cell wall and immune response. Springer, Heidelberg, Germany.
  160. Vaden SL, Heit MC, Manaugh C, Riviere J. 1997. Fluconazole in cats: pharmacokinetics following intravenous and oral administration and penetration into cerebrospinal fluid, aqueous humour and pulmonary epithelial lining fluid. J Vet Pharmacol Ther 20:181-186.
  161. Velagapudi R, Hsueh YP, Geunes-Boyer S, et al. 2009. Spores as infectious propagules of Cryptococcus neoformans. Infect Immun 77:4345-4355.
  162. Viviani MA, Cogliati M, Esposto MC, et al. 2006. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEMS Yeast Res 6:614-619.
  163. Walker C, Malik R, Canfield PJ. 1995. Analysis of leucocytes and lymphocyte subsets in cats with naturally occurring cryptococcosis but differing feline immunodeficiency virus status. Aust Vet J 72:93-97.
  164. Warren RJ, Perceval A, Dwyer BW. 1993. Comparative evaluation of cryptococcal latex tests. Pathology 25:76-80.
  165. Wilkes BL, Mayorga ME, Edman U, et al. 1996. Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type. Proc Nat Acad Sci USA 93:7327-7331.
  166. Windsor RC, Sturges BK, Vernau KM, et al. 2009. Cerebrospinal fluid eosinophilia in dogs. J Vet Intern Med 23:275-281.
  167. Wray JD, Sparkes AH, Johnson EM. 2008. Infection of the subcutis of the nose of a cat caused by Mucor species: successful treatment using posaconazole. J Feline Med Surg 10:523-527.
  168. Yauch LE, Lam JS, Levitz SM. 2006. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PloS Pathog 2:e120.
  169. Zaisser A, Kresken JG, Weber A, et al. 2001. A case report of cryptococcosis in cat. Kleintierpraxis 46:581-586.